Atlas Trials

Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy Resistance

Clinical trial NCT05906329 · UNKNOWN

Trial details

NCT number
NCT05906329
Sponsor
Qianfoshan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Cancer Patients
Start date
2022-12-31
Primary completion
2023-06-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.